ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,412,610 | -7.4% | 94,427 | +3.9% | 0.00% | 0.0% |
| Q2 2023 | $2,605,291 | +44.3% | 90,840 | +20.6% | 0.00% | – |
| Q1 2023 | $1,805,924 | +39.0% | 75,341 | -1.6% | 0.00% | – |
| Q4 2022 | $1,298,830 | +15.9% | 76,582 | +1.3% | 0.00% | – |
| Q3 2022 | $1,121,000 | +3.4% | 75,596 | +9.7% | 0.00% | – |
| Q2 2022 | $1,084,000 | -48.3% | 68,885 | -11.4% | 0.00% | – |
| Q1 2022 | $2,097,000 | -27.4% | 77,770 | -0.3% | 0.00% | -100.0% |
| Q4 2021 | $2,888,000 | -21.3% | 78,038 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $3,669,000 | +53.2% | 76,777 | +8.5% | 0.00% | – |
| Q2 2021 | $2,395,000 | -21.4% | 70,769 | -4.1% | 0.00% | -100.0% |
| Q1 2021 | $3,047,000 | -13.5% | 73,785 | -9.1% | 0.00% | 0.0% |
| Q4 2020 | $3,522,000 | +30.7% | 81,213 | +29.3% | 0.00% | 0.0% |
| Q3 2020 | $2,694,000 | +9.0% | 62,789 | +18.7% | 0.00% | 0.0% |
| Q2 2020 | $2,472,000 | – | 52,892 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,400 | $1,784,000 | 2.46% |
| Integral Health Asset Management, LLC | 130,000 | $1,927,000 | 0.37% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 20,916 | $310,000 | 0.34% |
| Green Alpha Advisors, LLC | 23,362 | $346,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 1,459,415 | $21,162,000 | 0.27% |
| ARK Investment Management | 2,181,703 | $32,333,000 | 0.22% |
| Woodline Partners LP | 877,524 | $13,005,000 | 0.18% |
| FEDERATED HERMES, INC. | 3,567,497 | $52,870,000 | 0.16% |
| NinePointTwo Capital LLC | 12,417 | $184,000 | 0.07% |
| Formidable Asset Management, LLC | 15,650 | $261,000 | 0.06% |